Upregulation of Major Histocompatibility Complex Class I on Liver Cells by Hepatitis C Virus Core Protein via p53 and TAP1 Impairs Natural Killer Cell Cytotoxicity

Kerstin Herzer(German Cancer Research Center), Christine S. Falk(National Institute for Public Health and the Environment), Jens Encke(Heidelberg University), Sören T. Eichhorst(Ludwig-Maximilians-Universität München), Axel Ulsenheimer(Institute of Immunology), Barbara Seliger(Johannes Gutenberg University Mainz), Peter H. Krammer(German Cancer Research Center)
Journal of Virology
July 12, 2003
Cited by 128Open Access
Full Text

Abstract

The mechanisms of immune evasion and the role of the early immune response in chronic infection caused by hepatitis C virus (HCV) are still unclear. Here, we present evidence for a cascade of molecular events that the virus initiates to subvert the innate immune attack. The HCV core protein induced p53-dependent gene expression of TAP1 (transporter associated with antigen processing 1) and consecutive major histocompatibility complex (MHC) class I upregulation. Moreover, in p53-deficient liver cell lines, only reconstitution with wild-type p53, but not mutated p53 lacking DNA binding capacity, showed this effect. As a consequence of increased MHC class I expression, a significantly downregulated cytotoxic activity of natural killer (NK) cells against HCV core-transfected liver cells was observed, whereas lysis by HCV-specific cytotoxic T cells was not affected. These results demonstrate a way in which HCV avoids recognition by NK cells that may contribute to the establishment of a chronic infection.


Related Papers

No related papers found

Powered by citation graph analysis